Category: Press Releases

Woman doctor examining x-ray

July 25, 2018

Biotechnology Press Releases Start-ups Duke biotech startup Cereius lands $6.75M in new capital

[Originally posted on Cereius, July 24, 2018] Cereius, Inc. Announces...

Humacyte's blood vessel graft

March 27, 2019

Duke Innovations Biotechnology Medicine Innovation Press Releases Start-ups Humacyte Turns Acellular Vessels into Living Blood Vessels

Science Translational Medicine Publishes Results That Humacyte’s “Human Acellular Vessels...


September 18, 2019

Press Releases Clinical Trials Start-ups Precision BioSciences Announces FDA Clearance of the IND for PBCAR20A

Precision BioSciences, Inc. (Nasdaq: DTIL), a genome editing company dedicated...

images from the istari oncology data where you can visibly see the impact of PVSRIPO. Leg with sores getting progressively better

November 9, 2020

Press Releases Start-ups Istari Oncology Presents Positive Data from Phase 1 Study

Istari Oncology Presents Positive Data from Phase 1 Study of...


June 16, 2021

Medicine Press Releases Duke News Antibody Targets Mechanism That Enables Lung Cancer to Grow and Spread

By Sarah Avery DURHAM, N.C. – An investigational antibody in...


September 4, 2018

Press Releases Start-ups Collaboration between University of Pennsylvania and Precision Biosciences to Develop Genome Editing Therapeutics

  DURHAM, North Carolina, USA, September 04, 2018 – Precision BioSciences...

Wall Street and Broad Street signs, color toning applied, New York City, USA.

April 3, 2019

Press Releases Start-ups Precision BioSciences Announces Closing of IPO

Duke start-up, Precision BioSciences, has closed its initial public offering...

Laptop showing before and after using Phitonex florescent biomarkers

October 10, 2019

Duke Innovations Press Releases Start-ups Phitonex Announces $2M Seed Funding

Fluorescent Dye Platform Will Enable New Breadth and Depth in...

Basking Bioscience Logo, blue and purple head outline with dna helix

December 7, 2020

Duke Innovations Press Releases Start-ups Basking Biosciences, Inc. Completes $5.4M Seed Financing

Funding to support development of the first reversible thrombolytic therapy...